Clinical Trials Arena Excellence Awards 2024: IQVIA

IQVIA’s Supply Automation Value Engine (SAVE) is revolutionizing clinical trial supply management, earning the company the 2024 Clinical Trials Excellence Award for Innovation. Clinical trials often face logistical challenges, particularly in managing investigational product (IP) shipments. SAVE addresses these issues by leveraging real-time Interactive Response Technology (IRT) to automate and optimize supply strategies, reducing errors, stock-outs, and overstocking.

By dynamically adjusting buffer stock levels and forecasting patient needs, SAVE reduces shipments by 74% and lowers costs, saving $150,000 to over $1 million annually for trial sponsors. Additionally, its predictive analytics enhance patient safety by ensuring timely drug availability.

Beyond cost savings, SAVE contributes to sustainability by minimizing waste and carbon footprint. As clinical trials grow in complexity, advanced IRT tools like SAVE are becoming essential for streamlining operations and accelerating drug development. IQVIA remains at the forefront of innovation, empowering sponsors with data-driven solutions that improve healthcare outcomes.